Silence Therapeutics (SLN) Earnings
|
Expand Research on SLN
| Next EPS Date | 8/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +6.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.1% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.14 | N/A | N/A | $1.4M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.11 | -$0.14 | +$0.03 | $400K | $1.32M | N/A |  | | Details | |
| 3/18/26 |
Q425 | N/A | -$0.20 | N/A | N/A | $8.16M | N/A | N/A | N/A | ||
| 11/18/25 |
Q325 | N/A | -$0.19 | N/A | N/A | $4.38M | N/A | N/A | N/A | ||
| 8/14/25 |
Q225 | N/A | -$0.13 | N/A | N/A | $6.93M | N/A | N/A | N/A | ||
| 5/14/24 | Q124 | N/A | -$0.11 | N/A | N/A | $13.95M | N/A | N/A | N/A | ||
| 3/13/24 | Q423 | N/A | -$0.08 | N/A | N/A | $8.88M | N/A | N/A | N/A | ||
| 11/14/23 | Q323 | -$0.07 | -$0.17 | +$0.10 | $2.8M | $2.94M | N/A | | | Details |
